Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease
Amine Majdi, Lynda Aoudjehane, Vlad Ratziu, et al.
Journal of Hepatology (2019) Vol. 72, Iss. 4, pp. 627-635
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Yana Geng, Klaas Nico Faber, Vincent E. de Meijer, et al.
Hepatology International (2021) Vol. 15, Iss. 1, pp. 21-35
Open Access | Times Cited: 253
Cell Death in Liver Diseases: A Review
Layla Shojaie, Andrea Iorga, Lily Dara
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9682-9682
Open Access | Times Cited: 219
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 195
Ferroptosis in liver disease: new insights into disease mechanisms
Jing Wu, Yi Wang, Rongtao Jiang, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 178
Lytic cell death in metabolic liver disease
Jérémie Gautheron, Gregory J. Gores, Cecília M. P. Rodrigues
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 394-408
Open Access | Times Cited: 167
Necroptosis contributes to chronic inflammation and fibrosis in aging liver
Sabira Mohammed, Nidheesh Thadathil, Ramasamy Selvarani, et al.
Aging Cell (2021) Vol. 20, Iss. 12
Open Access | Times Cited: 117
The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
Lili Yu, Wei Hong, Shen Lu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 80
Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease
Tobias Puengel, Hanyang Liu, Adrien Guillot, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2668-2668
Open Access | Times Cited: 74
Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases
Lian Wang, Yanghui Zhu, Lu Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 41
Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation
Cédric Peleman, Sven Francque, Tom Vanden Berghe
EBioMedicine (2024) Vol. 102, pp. 105088-105088
Open Access | Times Cited: 18
Mediators of necroptosis: from cell death to metabolic regulation
Xiaoqin Wu, Laura E. Nagy, Jérémie Gautheron
EMBO Molecular Medicine (2024) Vol. 16, Iss. 2, pp. 219-237
Open Access | Times Cited: 17
Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress
Sabira Mohammed, Evan H. Nicklas, Nidheesh Thadathil, et al.
Free Radical Biology and Medicine (2021) Vol. 164, pp. 315-328
Open Access | Times Cited: 91
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
Marta B. Afonso, Pedro M. Rodrigues, Miguel Mateus‐Pinheiro, et al.
Gut (2020) Vol. 70, Iss. 12, pp. 2359-2372
Open Access | Times Cited: 84
RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages
Liang Tao, Yuguo Yi, Yuxin Chen, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 4, pp. 1418-1433
Open Access | Times Cited: 81
Why Do So Many Nonalcoholic Steatohepatitis Trials Fail?
Vlad Ratziu, Scott L. Friedman
Gastroenterology (2020) Vol. 165, Iss. 1, pp. 5-10
Closed Access | Times Cited: 71
CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis
Hongxue Shi, Xiaobo Wang, Fang Li, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 672
Open Access | Times Cited: 44
SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation
Lingjie Yan, Tao Zhang, Kai Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis
Ying Zhou, Ruoman Wu, Xinqi Wang, et al.
Cell Proliferation (2022) Vol. 55, Iss. 3
Open Access | Times Cited: 40
Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation
Ren Guo, Xiaohui Jia, Zhen–Bin Ding, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 5220-5236
Open Access | Times Cited: 38
NLRP3: a new therapeutic target in alcoholic liver disease
Subhashini Brahadeeswaran, Tiasha Dasgupta, Venkatraman Manickam, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 13
Adenosine triphosphate-binding pocket inhibitor for mixed lineage kinase domain-like protein attenuated alcoholic liver disease via necroptosis-independent pathway
Huiqing Yuan, Hyun Sung Kim, Gye Ryeol Park, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 6
Closed Access | Times Cited: 1
Stable Transmission of DNA Methylation Epimutations from Germlines to the Liver and Their Association with Fatty Liver Disease in Medaka
Sourav Chakraborty, Santosh Anand, Xuegeng Wang, et al.
Research Square (Research Square) (2025)
Closed Access | Times Cited: 1
Mitochondrial Mechanisms of Necroptosis in Liver Diseases
Chen Xue, Xinyu Gu, Ganglei Li, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 66-66
Open Access | Times Cited: 50
Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy
Jianan Zhao, Yiyang Hu, Jinghua Peng
Cellular & Molecular Biology Letters (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top